Location History:
- Chiba, JP (2015 - 2017)
- Kashiwa, JP (2017)
- Tokyo, JP (2018)
Company Filing History:
4 out of 38 
4 out of 5 
3 out of 222 
Years Active: 2015-2018
Title: Innovations in Oncology: The Contributions of Hiroyasu Esumi
Introduction
Hiroyasu Esumi is an accomplished inventor based in Chiba, Japan, known for his significant contributions to the field of oncology through his innovative anticancer agents. With a strong portfolio of four patents, he has focused on developing solutions aimed at enhancing treatment efficacy and improving patient outcomes in the fight against cancer.
Latest Patents
One of Esumi's notable inventions is an anticancer agent designed to potentiate antitumor effects while alleviating side effects. This innovation combines arctigenin with other active components to strengthen tumor growth inhibition and reduce the proportion of cancer stem cells within tumors. Esumi's anticancer agent is posited as a combination drug or a kit that utilizes a formulation containing arctigenin alongside another formulation with a parallel anticancer effect. Furthermore, he has also developed a novel anticancer agent employing burdock fruit extract, demonstrating effective tumor reduction in pancreatic cancer patients when administered with a daily dose of arctigenin of 100 mg or more. This invention indicates a promising weight ratio of arctigenin to arctiin, ranging from 0.7 to 1.3, to optimize therapeutic outcomes.
Career Highlights
Esumi's career includes notable positions at prestigious institutions such as the University of Toyama and Kracie Pharma, Ltd. His academic and professional journey reflects a commitment to advancing research and innovation in cancer treatment, showcasing his dedication to developing therapies that have the potential to significantly improve patient care.
Collaborations
Throughout his career, Hiroyasu Esumi has collaborated with esteemed colleagues, including Toshiki Okubo and Satoshi Yomoda. These partnerships have played an essential role in his research endeavors and have contributed to the successful development of his patented inventions.
Conclusion
Hiroyasu Esumi’s contributions to the field of oncology through his patents not only highlight his innovative spirit but also his dedication to improving cancer treatment. As research continues to evolve, his inventions in anticancer agents may pave the way for more effective therapies, offering hope to patients and healthcare professionals alike.